Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or

Globus Medical Inc (GMED)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,099,176
  • Shares Outstanding, K 98,990
  • Annual Sales, $ 712,970 K
  • Annual Income, $ 156,470 K
  • 60-Month Beta 0.79
  • Price/Sales 5.79
  • Price/Cash Flow 19.32
  • Price/Book 3.34

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/19
See More
  • Average Estimate 0.42
  • Number of Estimates 5
  • High Estimate 0.42
  • Low Estimate 0.40
  • Prior Year 0.44
  • Growth Rate Est. (year over year) -4.55%

Price Performance

See More
Period Period Low Period High Performance
1-Month
40.18 +0.95%
on 05/23/19
46.17 -12.15%
on 05/02/19
-4.73 (-10.44%)
since 04/23/19
3-Month
40.18 +0.95%
on 05/23/19
49.89 -18.70%
on 04/01/19
-7.12 (-14.93%)
since 02/22/19
52-Week
38.01 +6.71%
on 01/03/19
57.83 -29.86%
on 11/08/18
-12.28 (-23.24%)
since 05/23/18

Most Recent Stories

More News
New clinical data demonstrates the versatility of Globus Medical's ExcelsiusGPS(R)

Globus Medical (NYSE: GMED), a leading musculoskeletal solutions company today announced the results of a clinical study that evaluated the versatility of ExcelsiusGPS Robotic navigation system compared...

GMED : 40.56 (-2.05%)
Globus Medical (GMED) Q1 Earnings Miss, Revenues Grow Y/Y (Revised)

Globus Medical (GMED) management states that the first quarter of a year poses a seasonal challenge to the company's capital equipment, which grossly affects its sales in Q1.

ABT : 75.63 (-0.83%)
GMED : 40.56 (-2.05%)
SYK : 184.50 (-0.78%)
CNMD : 80.99 (-0.63%)
Globus Medical I Set to Possibly Rebound After Yesterday's Selloff of 6.57%

Globus Medical I (NYSE:GMED) traded in a range yesterday that spanned from a low of $41.63 to a high of $43.35. Yesterday, the shares fell 6.6%, which took the trading range below the 3-day low of $43.97...

GMED : 40.56 (-2.05%)
Globus Medical (GMED) Q1 Earnings Miss Mark, Margins Weak

Globus Medical (GMED) management states that the first quarter of a year poses a seasonal challenge to the company's capital equipment, which grossly affects its sales in Q1.

ABT : 75.63 (-0.83%)
GMED : 40.56 (-2.05%)
SYK : 184.50 (-0.78%)
CNMD : 80.99 (-0.63%)
Globus Medical (GMED) Q1 Earnings and Revenues Miss Estimates

Globus Medical (GMED) delivered earnings and revenue surprises of -12.20% and -1.90%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

GMED : 40.56 (-2.05%)
Globus Medical: 1Q Earnings Snapshot

AUDUBON, Pa. (AP) _ Globus Medical Inc. (GMED) on Thursday reported first-quarter earnings of $33.2 million.

GMED : 40.56 (-2.05%)
Globus Medical Reports First Quarter 2019 Results

Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced its financial results for the first quarter ended March 31, 2019.

GMED : 40.56 (-2.05%)
Globus Medical (GMED) Reports Next Week: What Awaits?

Globus Medical (GMED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

GMED : 40.56 (-2.05%)
Markel Corporation Names New Vice President of Manufacturing Operations to Drive Lean Six Sigma Change

Markel Corporation, the leading industrial technology manufacturing company making fluoropolymer-based products, today announced that Rick Kreppel has joined the team as Vice...

GMED : 40.56 (-2.05%)
GE : 9.56 (-3.43%)
MKL : 1,064.59 (-2.01%)
Detailed Research: Economic Perspectives on America First Multifamily Investors, Pluralsight, Globus Medical, ContraFect, Moleculin Biotech, and RumbleON -- What Drives Growth in Today's Competitive Landscape

In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders, and shareholders of America First Multifamily Investors,...

PS : 33.09 (-1.19%)
RMBL : 4.78 (-2.25%)
ATAX : 7.08 (-0.56%)
GMED : 40.56 (-2.05%)
CFRX : 0.41 (-6.13%)
MBRX : 1.12 (-2.61%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators mostly agree with the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Trade GMED with:

Business Summary

Globus Medical, Inc. is a medical device company focused on the design, development and commercialization of products that promote healing in patients with spine disorders. The Company's products fall into one of two categories: innovative fusion or disruptive technologies. Its innovative fusion products...

See More

Key Turning Points

2nd Resistance Point 42.27
1st Resistance Point 41.41
Last Price 40.56
1st Support Level 39.94
2nd Support Level 39.33

See More

52-Week High 57.83
Fibonacci 61.8% 50.26
Fibonacci 50% 47.92
Fibonacci 38.2% 45.58
Last Price 40.56
52-Week Low 38.01

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar